Bose et al., performed an analysis of the genomic landscape of 102 patients with unclassifiable MDS/MPN syndrome and further confirmed that women have a higher incidence of DNMT3A mutations while mutations in the ASXL1 gene were more common among men [31]. This evidence concerns the gene DNMT3A and myelodysplastic syndrome.